Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients

(MedPage Today) — A phase III trial of investigational valiltramiprosate (ALZ-801) did not meet its primary endpoint in people with early symptomatic Alzheimer’s disease, but the drug did show benefits in a prespecified population with mild cognitive…

Source link : https://www.medpagetoday.com/meetingcoverage/ctad/118794

Author :

Publish date : 2025-12-02 19:26:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

Ancient human artefacts found near caves in Arabian desert

Doctors Have a Front-Row Seat to the Caregiver Crisis

Related Posts

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

FDA Requests Removal of Suicide Warning on GLP-1s

Flu Antiviral Use Among Hospitalized Kids Fell During COVID Pandemic

Cancer Waits Missed at Essex Trust, Ombudsman Finds

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

FDA Requests Removal of Suicide Warning on GLP-1s

Flu Antiviral Use Among Hospitalized Kids Fell During COVID Pandemic

Cancer Waits Missed at Essex Trust, Ombudsman Finds

Addressing Fear and Uncertainty in Chronic Lymphocytic Leukemia

Intervention to Get Patients Off Benzos Succeeds in Trial

Categories

Archives